Andrew Pierce

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Andrew Pierce and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Andrew

Andrew Pierce

VP Translational Biology

Cresendo Biologics

Eighteen years directing and mentoring teams of Ph.Ds. and associates translating science into clinical oncology drug development: 10 in industry and 8 in academia.

Talks About
#leadership

Preferred Locations
#Europe

Speaking Engagements

Lag-3 Targeted Drug Development Summit

Paid

With the recent clinical validation by BMS, LAG-3 combinations are spearheading the next wave of immune checkpoint inhibitors. As such, there has been an explosion of interest and high-scale investment into this exciting space.

25-27 January 2022

Healthcare

11th PREDiCT: Tumour Models London Summit

Paid

With next generation of complex immuno-oncology candidates, preclinical and translational scientists in the IO space are in need for more predictive tumour models to improve clinical translatability, accelerating speed-to-clinic with confidence.

07-08 December 2022

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Andrew Pierce

VP Translational Biology

Speaking Engagements

Lag-3 Targeted Drug Development Summit

11th PREDiCT: Tumour Models London Summit